SCHEMBL5173124

SCHEMBL5173124

CNC(=O)[CH]Cc1ccc(O[C@@H](C)C(N)=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
EPHX1 P07099 1/20 0.38
CYP1A2 P05177 2/20 0.38
GAA P10253 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP2D6 P10635 1/20 0.38
GLA P06280 1/20 0.37
PARP10 Q53GL7 1/20 0.36
EPHX2 P34913 2/20 0.36
ADRB3 P13945 5/20 0.35
CYP2C9 P11712 1/20 0.35
PKM P14618 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TAS1R2 Q8TE23 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL630790 0.77 GLA (0.53) ALDH1A1POLBCYP1A2GAACYP2C19
SCHEMBL5170755 0.77 TSHR (0.54) POLBGAAPKM
SCHEMBL28622034 0.71 CYP2C19 (0.47) ALDH1A1POLBCYP1A2GAACYP2C19
SCHEMBL3462801 0.70 NPC1 (0.54) ALDH1A1PARP10
SCHEMBL8613306 0.70 PARP10 (0.48) ALDH1A1POLBCYP1A2GAACYP2C19
SCHEMBL15652500 0.70 PARP10 (0.48) ALDH1A1POLBCYP1A2GAACYP2C19
SCHEMBL7074556 0.70 KMT2A (0.54) ALDH1A1POLBCYP1A2GAACYP2C19
SCHEMBL8612180 0.70 PARP10 (0.48) ALDH1A1POLBCYP1A2GAACYP2C19
SCHEMBL7074553 0.70 KMT2A (0.54) ALDH1A1POLBCYP1A2GAACYP2C19
SCHEMBL31147135 0.70 PARP10 (0.48) ALDH1A1POLBCYP1A2GAACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP claimed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO claimed
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP disclosed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO disclosed